News
TVGN
0.8200
-7.87%
-0.0700
TEVOGEN BIO HOLDINGS - SUBSTANTIAL DOUBT EXISTS ABOUT ABILITY TO CONTINUE AS GOING CONCERN FOR ONE YEAR FROM UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS TO BE ISSUED
Reuters · 1d ago
Press Release: Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives
Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives. Mr. Keane brings 35 years of leadership experience in law enforcement. Tevogen is a clinical-stage specialty immunotherapy biotech pioneer developing genetically unmodified T cell therapies.
Dow Jones · 1d ago
APP, MGNX and CYCC among pre-market losers
On the Move APP, MGNX and CYCC among pre-market losers. Augmedix (AUGX) -38% reports Q1 results. Inotiv (NOTV) will report fiscal 2024 second quarter financial results on May 15, 2024.
Seeking Alpha · 4d ago
Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Akoustis Technologies, Inc. Fell sharply in today's session following weak quarterly results. GameStop Corp. Shares jumped amid possible retail investor interest following a social media post by Roaring Kitty. AC Immune SA gained 31% to $ after the company reported first-quarter financial results.
Benzinga · 4d ago
Why Tevogen Bio Holdings Stock Is Moving Higher Today
Tevogen Bio Holdings Inc. Shares are rising after the company secured up to $50 million of financing from an existing investor. The financing is aimed at supporting research and development efforts for Tevogen’s TVGN 489. The company also plans to start clinical trials for virally induced cancers and multiple sclerosis.
Benzinga · 5d ago
Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today?
TransCode Therapeutics (NASDAQ:RNAZ) stock is sliding lower on Monday following its announcement of an upcoming annual shareholder meeting. Shares of RNAZ stock are down due to its plans for a reverse stock split. Investors will find more of the hottest stock market news for Monday. Safe & Green Development stock, AC Immune stock and Tevogen Bio stock are also down today.
Investorplace · 5d ago
Market-Moving News for May 13th
GameStop shares trading higher amid possible retail investor interest. AC Immune shares are trading higher after the company reported Q1 financial results. Tevogen Bio Holdings shares are also trading higher. The company announced a deal to secure $50 million of financing for a potential Alzheimer's drug.
Benzinga · 5d ago
Why Is Safe & Green Development (SGD) Stock Down 5% Today?
Safe & Green Development (NASDAQ:SGD) stock is down on Monday after the company filed a Form D with the SEC. The company is selling $ million in securities for the first time. Only 322,000 shares of the company’s stock have changed hands as of Monday morning. InvestorPlace offers insight into the latest stock market news for Monday. AC Immune and Tevogen Bio are the biggest pre-market stock movers this morning.
Investorplace · 5d ago
Why Is AC Immune (ACIU) Stock Up 45% Today?
AC Immune (NASDAQ:ACIU) stock is up 45% as of Monday morning. AC Immune has a new collaboration agreement with Takeda Pharmaceutical. The company's earnings report for the first quarter of 2024 includes an update to its clinical trial of a new drug. Tevogen Bio (NASdaq:TVGN) is up 54% on Monday.
Investorplace · 5d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tevogen Bio Holdings (NASDAQ:TVGN) stock rose to $ during Monday's pre-market session. The company's market cap stands at $ billion. Applied DNA Sciences stock declined by $ during the pre- market session. Tevogen Bio is one of several companies in the biotech sector.
Benzinga · 5d ago
Why Is Tevogen Bio (TVGN) Stock Up 54% Today?
Tevogen Bio (NASDAQ:TVGN) stock is rocketing higher on Monday after announcing an additional $50 million in financing. The company will use the money to continue the development of its first product, TVGN 489. More than a million shares of TVGN stock are changing hands as of Monday morning.
Investorplace · 5d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Tevogen Bio stock is rocketing more than 71% after announcing $50 million in additional financing. AC Immune shares are soaring over 48% alongside its Q1 2024 earnings report. The biggest pre-market stock movers on Monday morning are earnings reports, an acquisition deal, a delisting notice.
Investorplace · 5d ago
Weekly Report: what happened at TVGN last week (0506-0510)?
Weekly Report · 5d ago
Why JanOne Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
Shares of JanOne Inc. Rose sharply in today's pre-market trading. The company announced plans to acquire ALT 5 Sigma Inc. In the week of May 13th. Tevogen Bio Holdings Inc. And Groupon, Inc. Were among the stocks moving in pre- market trading.
Benzinga · 5d ago
Tevogen Bio Entered Into A Binding Term Sheet With An Existing Investor To Secure Up To $50M Of Financing
Supports expansion of Tevogen's ExacTcell™ platform toward additional clinical trials. Bolsters a financial path to positive cashflow and minimizes dilution. The financing will also be used to start additional clinical studies for virally induced cancers and multiple sclerosis. Teevogen Bio has entered into a binding term sheet to secure up to $50 million.
Benzinga · 05/10 22:49
Tevogen Bio secures up to $50M in financing
Tevogen Bio has entered into a binding term sheet with an existing investor to secure up to $50M in financing. The company expects the financing to close by the end of Q2. Tevogen Bio will focus on expanding research and development of its product, TVGN 489.
Seeking Alpha · 05/10 21:46
Press Release: Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
Tevogen Bio Announces Up to $50 million in Financing to Further Advance Operational Objectives. The financing supports expansion of Tevogen's ExacTcell platform toward additional clinical trials. The company's initial product, TVGN 489, is being developed for the treatment of high-risk patients.
Dow Jones · 05/10 21:40
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength to its price action. Tevogen Bio Holdings Inc. Has an RSI value of 19.57.
Benzinga · 05/07 11:18
Weekly Report: what happened at TVGN last week (0429-0503)?
Weekly Report · 05/06 10:54
Tevogen Bio Holdings Inc. reports FY results
Seeking Alpha · 05/01 18:19
More
Webull provides a variety of real-time TVGN stock news. You can receive the latest news about Tevogen Bio through multiple platforms. This information may help you make smarter investment decisions.
About TVGN
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, is an off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy designed to fill a critical gap in COVID-19 therapeutic solutions for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of Long COVID. In addition to TVGN 489, it has several product candidates under early-stage development. The Company is developing Epstein-Barr virus (EBV) specific CTLs for potential use in multiple sclerosis (MS) and EBV-associated lymphomas. Its TVGN 601 is being developed for MS, and its TVGN 930 is being developed for EBV-associated lymphomas.